Activated platelets have been implicated in playing a major role in transfusion-related acute lung injury (TRALI), as platelets can trigger neutrophils, resulting in vascular damage. We hypothesized that binding of platelet CD40 ligand (CD40L) to endothelial CD40 is essential in the onset of TRALI. Mice were challenged with monoclonal major histocompatibility complex (MHC)-1 antibody which induced TRALI, evidenced by pulmonary oedema, accompanied by significantly elevated bronchoalveolar fluid (BALF) levels of total protein and elevated plasma levels of keratinocyte-derived chemokine (KC) and macrophage inflammatory protein-2 (MIP-2) compared to infusion of isotype antibody (all Ps<0·05). Treatment with ciglitazone, which inhibits platelet ...
Rationale: Acute lung injury (ALI) causes high mortality, but its molecular mechanisms and therapeut...
Background and objectives: Platelet-derived CD40L is known to regulate neutrophil recruitment and lu...
<div><p>Pathogen reduction technology (PRT) has been developed in an effort to make the blood supply...
Introduction – Transfusion Related Acute Lung Injury is an inflammatory syndrome which can develop a...
The CD40 ligand (CD40L) is a transmembrane molecule of crucial interest in cell signaling in innate ...
Transfusion-related acute lung injury (TRALI) is a significant cause of post-transfusion morbidity a...
Platelets are versatile cells which are capable of eliciting nonhemostatic immune functions, especia...
Transfusion-related acute lung injury (TRALI) can occur during or after a transfusion, and remains a...
Transfusion-related acute lung injury (TRALI) is a major cause of transfusion-related mortality. Cau...
A key component of the ability to resuscitate or revive badly injured or ill patients involves trans...
Background and Objectives Transfusion-related acute lung injury (TRALI) is characterized by leukocyt...
CD40-CD40L interactions have been involved in inflammation and thrombosis. Several diseases are char...
Transfusion-related acute lung injury (TRALI) is still one of the leading causes of transfusion-asso...
PURPOSE: Tumor-induced platelet activation may cause the release of various cytokines, including CD4...
Transfusion-related acute lung injury (TRALI) is a serious transfusion complication that may lead to...
Rationale: Acute lung injury (ALI) causes high mortality, but its molecular mechanisms and therapeut...
Background and objectives: Platelet-derived CD40L is known to regulate neutrophil recruitment and lu...
<div><p>Pathogen reduction technology (PRT) has been developed in an effort to make the blood supply...
Introduction – Transfusion Related Acute Lung Injury is an inflammatory syndrome which can develop a...
The CD40 ligand (CD40L) is a transmembrane molecule of crucial interest in cell signaling in innate ...
Transfusion-related acute lung injury (TRALI) is a significant cause of post-transfusion morbidity a...
Platelets are versatile cells which are capable of eliciting nonhemostatic immune functions, especia...
Transfusion-related acute lung injury (TRALI) can occur during or after a transfusion, and remains a...
Transfusion-related acute lung injury (TRALI) is a major cause of transfusion-related mortality. Cau...
A key component of the ability to resuscitate or revive badly injured or ill patients involves trans...
Background and Objectives Transfusion-related acute lung injury (TRALI) is characterized by leukocyt...
CD40-CD40L interactions have been involved in inflammation and thrombosis. Several diseases are char...
Transfusion-related acute lung injury (TRALI) is still one of the leading causes of transfusion-asso...
PURPOSE: Tumor-induced platelet activation may cause the release of various cytokines, including CD4...
Transfusion-related acute lung injury (TRALI) is a serious transfusion complication that may lead to...
Rationale: Acute lung injury (ALI) causes high mortality, but its molecular mechanisms and therapeut...
Background and objectives: Platelet-derived CD40L is known to regulate neutrophil recruitment and lu...
<div><p>Pathogen reduction technology (PRT) has been developed in an effort to make the blood supply...